Michael Langford v. Monsanto et al

Reference :

CGC-21-592238

Complaint date :

June 15, 2021

Status :

Not judged

Place of jurisdiction :

United States

Plaintiffs types :

Individuals

Plaintiffs names :

Michael Langford

Defendants :

Monsanto, Wilbur-Ellis, John Does 1-50

Lawyers for Health and Environmental Justice :

Jennifer Moore, Elizabeth Graham, Brent Wisner, Tudor Farcas

Case nature :

Civil court

Type(s), Product(s), Active substance(s) :

Herbicide, Glyphosate, Roundup

Requests :

Compensatory and punitive damages ; awarding Plaintiffs their costs, expenses, and reasonable attorney’s fees incurred in this matter; further relief as the Court deems just and proper.

Name of the Court :

Superior Court of the State of California for the County of San Francisco, United States

Jurisdiction level :

Summary :

Michael Langford filed a complaint against Monsanto because he is suffering from non-Hodgkin's lymphoma (NHL) after having used Roundup herbicide between 1985 and 2019. He was diagnosed with NHL in 2007, and has since had five recurrences, multiple rounds of chemotherapyand a stem cell transplant. Plaintiff alleges strict liability – design defect and failure to warn, negligence, fraud, breach of express and implied warranties, and exemplary damages. On June 16, 2022, due to his worsening health conditions, plaintiff moves for an order granting a trial preference. On July 22, 2022, the Court grants plaintiff’s motion for preferential trial setting and sets the date of the trial at Nov. 7, 2022.

Scientific references :

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Some Organophosphate Insecticides and Herbicides. Lyon (FR): International Agency for Research on Cancer; 2017. PMID: 31829533.